FindTrial
Sign In

Retrospective Cohort Study on the Efficacy of Hyperbaric Oxygen Therapy in Sudden Sensorineural Hearing Loss from a Multidimensional Perspective

Retrospective Cohort Study on the Efficacy of Hyperbaric Oxygen Therapy in Sudden Sensorineural Hearing Loss from a Multidimensional Perspective

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500109047
Enrollment
Unknown
Registered
2025-09-10
Start date
2025-09-15
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sudden Sensorineural Hearing Loss

Interventions

Monotherapy group (Received only standardized pharmacological treatment (corticosteroids combined with vasodilators)):None
2.2 ATA group (In addition to pharmacological treatment, hyperbaric oxygen therapy was administered, with a pressure parameter of 2.2 ATA.):None
2.5 ATA group (In addition to pharmacological treatment, hyperbaric oxygen therapy was administered, with a pressure parameter of 2.5 ATA.):None

Sponsors

The Seventh Affiliated Hospital of Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1 >= 18 years old with sudden sensorineural hearing loss (onset within 72 hours and hearing loss =30dB); 2 Complete treatment and follow-up records.

Exclusion criteria

Exclusion criteria: 1 Baseline or post-treatment pure-tone audiometry (PTA) records are incomplete. 2 Patients with no clear records of treatment implementation.

Design outcomes

Primary

MeasureTime frame
Pure Tone Audiometry;—

Countries

China

Contacts

Public ContactQiang Lin

The Seventh Affiliated Hospital of Sun Yat-sen University

linqiang@sysush.com+86 189 2249 7674

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026